137 related articles for article (PubMed ID: 7861647)
1. [201Tl scintigraphic evaluation of tumor mass and viability of bone and soft-tissue tumors].
Tsuda T; Kubota M; Yoshida S; Shibata M; Wakabayashi J; Obata H; Matsuyama T; Usui M; Ishii S
Kaku Igaku; 1994 Dec; 31(12):1477-94. PubMed ID: 7861647
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors.
Nishiyama Y; Yamamoto Y; Yokoe K; Kawaguchi Y; Toyama Y; Satoh K; Ohkawa M
Ann Nucl Med; 2004 May; 18(3):235-41. PubMed ID: 15233285
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of bone and soft tissue lesion using 99mTc-MIBI: comparison with 201Tl and the relation to chemotherapeutic effect].
Sumiya H; Taki J; Tonami N; Asada N; Tsuchiya H; Tomita K
Kaku Igaku; 1997 Feb; 34(2):105-11. PubMed ID: 9095573
[TBL] [Abstract][Full Text] [Related]
4. Quantitative thallium-201 scintigraphy in childhood osteosarcoma: Comparison with technetuim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response.
Ilhan IE; Vural G; Berberoglu S; Kapucuoglu N; Cila A; Eke S
Pediatr Hematol Oncol; 2005 Mar; 22(2):153-62. PubMed ID: 15805001
[TBL] [Abstract][Full Text] [Related]
5. Value of thallium-201 scintigraphy in bone and soft tissue tumors.
Sato O; Kawai A; Ozaki T; Kunisada T; Danura T; Inoue H
J Orthop Sci; 1998; 3(6):297-303. PubMed ID: 9811980
[TBL] [Abstract][Full Text] [Related]
6. Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: comparison with Tl-201 imaging.
Taki J; Higuchi T; Sumiya H; Tsuchiya H; Minato H; Tomita K; Tonami N
J Orthop Res; 2008 Mar; 26(3):411-8. PubMed ID: 17960652
[TBL] [Abstract][Full Text] [Related]
7. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response.
Ramanna L; Waxman A; Binney G; Waxman S; Mirra J; Rosen G
J Nucl Med; 1990 May; 31(5):567-72. PubMed ID: 2341892
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
Goto Y; Ihara K; Kawauchi S; Ohi R; Sasaki K; Kawai S
J Orthop Sci; 2002; 7(3):304-12. PubMed ID: 12077654
[TBL] [Abstract][Full Text] [Related]
9. [Clinical usefulness of thallium-201 chloride in the diagnosis of tumor (II)--An evaluation in bone, soft tissue and mediastinal tumors].
Tonami N; Itoh K; Yui N; Terui S; Torizuka K
Kaku Igaku; 1994 Jan; 31(1):63-74. PubMed ID: 8309112
[TBL] [Abstract][Full Text] [Related]
10. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors.
Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Ohkawa M; Tanabe M
Clin Nucl Med; 2000 Mar; 25(3):200-5. PubMed ID: 10698418
[TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness of 201Tl-chloride scintigraphy for the evaluation of metastatic bone lesions].
Fukui A; Kawamura M; Kataoka M; Fujii T; Yamamoto K; Yoshioka S; Ikezoe J
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jan; 58(1):25-33. PubMed ID: 9493430
[TBL] [Abstract][Full Text] [Related]
13. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
Sugawara Y; Kikuchi T; Kajihara M; Semba T; Ochi T; Fujii T; Mochizuki T; Sakayama K; Nakata S
Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
[TBL] [Abstract][Full Text] [Related]
14. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
[TBL] [Abstract][Full Text] [Related]
15. The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors.
Caluser C; Macapinlac H; Healey J; Ghavimi F; Meyers P; Wollner N; Kalaigian J; Kostakoglu L; Abdel-Dayem HM; Yeh SD
Clin Nucl Med; 1992 Jul; 17(7):565-72. PubMed ID: 1638838
[TBL] [Abstract][Full Text] [Related]
16. Thallium-201 scintigraphy in pediatric soft-tissue tumors.
Howman-Giles R; Uren RF; Shaw PJ
J Nucl Med; 1995 Aug; 36(8):1372-6. PubMed ID: 7629580
[TBL] [Abstract][Full Text] [Related]
17. Tl-201 and Tc-99m HMDP scintigraphic findings in extraskeletal osteosarcoma.
Kajihara M; Sugawara Y; Miki H; Mochizuki T; Kidani T; Sakayama K
Clin Nucl Med; 2005 May; 30(5):356-8. PubMed ID: 15827415
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
Yamamoto Y; Kawaguchi Y; Kawase Y; Maeda Y; Nishiyama Y
Clin Nucl Med; 2011 Apr; 36(4):290-4. PubMed ID: 21368603
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative assessment of 201Tl-SPECT in tumors of bone and soft tissue].
Matsui R; Komori T; Nakata Y; Doi K; Tabuchi K; Saika Y; Utsunomiya K; Adachi I; Shimizu T; Sueyoshi K; Narabayashi I; Morishita S
Kaku Igaku; 1999 Apr; 36(3):219-28. PubMed ID: 10358956
[TBL] [Abstract][Full Text] [Related]
20. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
Ozcan Z; Burak Z; Erinç R; Dirlik A; Başdemir G; Sabah D; Ozkiliç H
Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
